Organization · Venture Capital
N1
N1 is an early-stage venture capital firm founded in 2019, with offices in San Francisco and Prague. It focuses on investing in AI, healthtech, and frontier technology startups across Europe and the United States.
Overview
What N1 does
What N1 is
N1 is an early-stage venture capital firm founded in 2019, with offices in San Francisco and Prague. It focuses on investing in AI, healthtech, and frontier technology startups across Europe and the United States.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- May 6, 2026
Official channels
Find N1 elsewhere
Open the official website or a supported primary organization account.
Capability profile
N1 as a funder
Investment thesis
N1 backs early-stage founders with global ambitions, focusing on AI and healthcare, and supports them in building companies that can scale internationally.
Focus narrative
N1 invests in early-stage companies primarily in the sectors of AI, healthtech, and frontier technology. The organization operates across Europe and the United States, managing $60 million across two funds. Their typical first investment ranges from $100,000 to $1 million, targeting innovative startups that are poised for significant growth.
Value beyond capital
N1 provides value to its portfolio companies through operational support, strategic guidance, and access to a vast network of industry connections. The investment team has startup-building experience, enabling them to assist founders in navigating challenges and accelerating growth.
Terms and economics
- Typical check
- $100,000–$1,000,000
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- North AmericaEurope
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 60
Portfolio context
N1 has invested in over 60 companies, including: Myriad AI: AI-powered regulatory compliance platform for heavily regulated industries. TrueClaim: Innovative claims solutions provider. Scalpel AI: Specializes in AI applications. NovoFlow: Develops AI assistants for clinic administration, including bookings and billing. Paratus Health: Offers healthcare support across voice, text, and chat. Parachute AI: Governance infrastructure for clinical AI. DeepAware AI: Monitors data centers to prevent energy waste. Mundo AI: Focuses on creating multilingual data for AI models. Superglue AI: Specializes in intelligent integration management and automated migration.
Common questions
What to know about N1
Upseed classifies N1 under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 6, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.